Table 4.
Summary of evidence from quantitative research syntheses
| Intervention | Number of systematic reviews/meta-analysis, total participants | First author, year | Primary results/findings | Rating the evidence of effectiveness | |
| Patients with acute coronary syndrome | |||||
| General health education | Six/161 997 patients (Goulding et al, 201051 did not give the total sample size) | Ghisi, 201450 | Knowledge | 91% studies* | Some evidence |
| Behaviour | 77%/84%/65% studies* | ||||
| Psychosocial indicators | 43% studies* | ||||
| Brown, 201337 | Mortality | ||||
| MI | |||||
| Revascularisations | |||||
| Hospitalisations | |||||
| HRQoL | |||||
| Withdrawals/dropouts | |||||
| Healthcare utilisation and costs | |||||
| Brown, 201170 | Total mortality | ||||
| MI | |||||
| CABG | |||||
| Hospitalisations | |||||
| HRQoL | 63.6% studies* | ||||
| Healthcare costs | 40% studies* | ||||
| Withdrawal/dropout | |||||
| Goulding, 201051 | Beliefs | 30.08% studies* | |||
| Secondary outcomes | |||||
| Fernandez, 200748 | Smoking | ||||
| Cholesterol level | |||||
| Multiple risk factor modification | |||||
| Kotb, 201459 | All-cause hospitalisation | ||||
| All-cause mortality | |||||
| Smoking cessation | |||||
| Depression | |||||
| Systolic blood pressure | |||||
| Low-density lipoprotein | |||||
| Anxiety | |||||
| Psychoeducational interventions | Six/37 883 patients | Barth, 201569 | Abstinence by self-report or validated | Sufficient evidence | |
| Dickens, 201345 | Depression | ||||
| Aldcroft, 201131 | Smoking cessation | ||||
| Physical activity | |||||
| Huttunen-Lenz,201056 | Prevalent smoking cessation | ||||
| Continuous smoking cessation | |||||
| Total mortality | |||||
| Barth, 200836 | Abstinence by self-report or validated | ||||
| Smoking status | |||||
| Barth, 200635 | Abstinence | ||||
| Smoking status | |||||
| Secondary prevention educational interventions (including Internet-based secondary prevention) | Three/25 154 patients | Devi, 201544 | Mortality | Some evidence | |
| Revascularisation | |||||
| Total cholesterol | |||||
| HDL cholesterol | |||||
| Triglycerides | |||||
| HRQOL | |||||
| Auer, 200834 | All-cause mortality | ||||
| Readmission rates | |||||
| Reinfarction rates | |||||
| Smoking cessation rates | |||||
| Clark, 200541 | Mortality | ||||
| MI | |||||
| Quality of life | Most of the included studies* | ||||
| Patients with T2DM | |||||
| General health education | Five/2319 patients (Choi et al, 201640; Loveman et al, 200860; Zabaleta et al, 200779 did not give the total sample size) | Choi, 201640 | HbA1c | Some evidence | |
| Saffari, 201474 | Glycaemic control | ||||
| Duke, 200946 | HbA1c | ||||
| BP | |||||
| Knowledge, psychosocial outcomes and smoking habits | No data | ||||
| Diabetes complications or health service utilisation and cost analysis | No data | ||||
| Loveman, 200860 | Diabetic control outcomes | 46.15% studies* | |||
| Weight | 66.67% studies* | ||||
| Cholesterol or triglycerides | 40.00% studies (+) | ||||
| Zabaleta, 200779 | HbA1c | 4.8% studies* | |||
| Culturally appropriate health education | Eight/20 622 patients (Ricci-Cabello et al, 201473 and Gucciardi et al, 201352 did not give the total sample size) | Creamer, 201642 | HbA1c | Some evidence | |
| HRQoL | |||||
| AEs | No AEs | ||||
| Ricci-Cabello, 201473 | HbA1c | ||||
| Diabetes knowledge | 73.3% studies* | ||||
| Behaviours | 75% studies* | ||||
| Clinical outcomes | Fasting blood glucose, HbA1c and BP improved in 71%, 59% and 57% of the studies | ||||
| Attridge, 201433 | HbA1c | ||||
| Knowledge scores | |||||
| Clinical outcomes | |||||
| Other outcome measures | Showed neutral effects | ||||
| Gucciardi, 201352 | HbA1c levels | 3 of 10 studies* | |||
| Anthropometrics | 3 of 11 studies* | ||||
| Physical activity | One of five studies* | ||||
| Diet outcomes | Two of six studies* | ||||
| Nam, 201262 | HbA1c level | ||||
| Hawthorne, 201054 | HbA1c | ||||
| Knowledge scores | |||||
| Khunti, 200858 | Knowledge levels | Only one study reporting a significant improvement | |||
| Biomedical outcomes | Only one study reporting a significant improvement | ||||
| Hawthorne, 200853 | HbA1c | ||||
| Knowledge scores | |||||
| Other outcome measures | |||||
| Lifestyle interventions+behavioural programme | Six/10 440 patients (Huang et al, 201655; Pillay et al, 201571 and Ramadas et al, 201177 did not give the total sample size) | Huang, 201655 | HbA1c | Some evidence | |
| BMI | |||||
| LDL-c and HDL-c | |||||
| Chen, 201539 | HbA1c | ||||
| BMI | |||||
| SBP | |||||
| DBP | |||||
| HDL-c | |||||
| Terranova, 201572 | HbA1c level | ||||
| Weight | |||||
| Pillay, 201571 | HbA1c levels | ||||
| BMI | |||||
| Ramadas, 201177 | HbA1c | 46.2% studies * | |||
| Gary, 200349 | Fast blood sugar | ||||
| Glycohaemoglobin | |||||
| HbA1 | |||||
| HbA1c | |||||
| Weight | |||||
| Self-management educational interventions | Nine/19 597 patients (Minet et al, 201061; Fan et al, 200947 and Norris et al, 200164 did not give the total sample size) | Pal, 201467 | Cardiovascular risk factors | Sufficient evidence | |
| Cognitive outcomes | |||||
| Behavioural outcomes | Only one study reporting a significant improvement | ||||
| AEs | No AEs | ||||
| Vugt, 201375 | Health behaviours | 7 of 13 studies * | |||
| Clinical outcomes measures | Nine studies * | ||||
| Psychological outcomes | Nine studies * | ||||
| Pal, 201368 | HbA1c | ||||
| Depression | |||||
| Quality of life | |||||
| Weight | |||||
| Steinsbekk, 201276 | HbA1c | ||||
| Main lifestyle outcomes | |||||
| Main psychosocial outcomes | |||||
| Minet, 201061 | Glycaemic control | ||||
| Fan, 200947 | Diabetes knowledge | ||||
| Overall self-management behaviours | |||||
| Overall metabolic outcomes | |||||
| Overall weighted mean effect sizes | |||||
| Deakin, 200543 | Metabolic control (HbA1c) | ||||
| Fasting blood glucose levels | |||||
| Weight | |||||
| Diabetes knowledge | |||||
| SBP | |||||
| Diabetes medication | |||||
| Norris, 200265 | Total GHb | ||||
| Norris, 200164 | Knowledge | ||||
| Self-monitoring of blood glucose | |||||
| Self-reported dietary habits | |||||
| Glycaemic control | |||||
| Therapeutic education | One/total sample: unclear | Odnoletkova, 201466 | Cost-effectiveness | Overall high in studies on prediabetes and varied in studies on T2DM | Insufficient evidence |
| Foot health education | One/total sample: unclear | Amaeshi32 | Diabetes complications | Some evidence | |
| Incidence of LEA | |||||
| Group medical visit | One/2240 patients | Burke, 201138 | HbA1c | Some evidence | |
| BP and DBP | |||||
| SBP | |||||
| Cholesterol—LDL | |||||
| Psychoeducational intervention | One/1431 patients | Alam, 200930 | HbA1c | Some evidence | |
| Psychological status | |||||
| Interventions aimed at improving adherence to medical treatment recommendations | Three/4907 patients (Lun Gan et al, 201157 did not give the total sample size) | Lun Gan, 201157 | Oral hypoglycaemic adherence | Five of seven studies * | Some evidence |
| Wens et al., 200878 | Adherence | General conclusions could not be drawn | |||
| Vermeire, 200580 | HbA1c | ||||
| Dietary advice | One/1467 patients | Nield, 200763 | Glycaemic control (addition of exercise to dietary advice) | Insufficient evidence to determine | |
| Weight | Limited data | ||||
| Diabetic microvascular and macrovascular diseases | Limited data | ||||
*Intervention group is significantly better than control group, for example, ‘91% studies ’ means 91% studies reported a significant better compared with control group.
AEs, adverse events; BMI, body mass index; BP, blood pessure; CABG, coronary artery bypass graft surgery; HbA1c, glycated haemoglobin; HRQoL, health related quality of life; LDL-c, low-density lipoprotein cholesterol; LEA, lower extremity amputation; MI, myocardial infarction; RCTs, randomised controlled trials; SBP, systolic blood pressure, DBP, diastolic blood pressure, HDL-c, high density lipoprotein cholesterol; T2DM, type two diabetes mellitus.